← Back to Search

Behavioral Intervention

Motivational Interview for Stroke

N/A
Recruiting
Led By Heather Panic, MD PhD
Research Sponsored by University of Florida
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patient presentation consistent with a stroke or TIA
Patient is a current tobacco user and tobacco use contributed to the stroke
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 90 days post-discharge
Awards & highlights

Study Summary

This trial is studying the impact of motivational interviewing (MI) on patients who have had a stroke or a transient ischemic attack (TIA) due to modifiable risk factors. The researchers want to

Who is the study for?
This trial is for current tobacco users who've had a stroke or TIA (mini-stroke) where smoking played a part. Participants must be able to follow up after discharge and engage in conversation, meaning they can't have severe cognitive impairments or speech issues that would prevent them from participating in an interview.Check my eligibility
What is being tested?
The study tests motivational interviewing led by trainees on patients with acute stroke or TIA due to lifestyle choices, compared to standard counseling. It aims to see if this approach improves patient outcomes and gives trainees a sense of fulfillment.See study design
What are the potential side effects?
Since the intervention involves only motivational interviews, there are no direct medical side effects. However, participants may experience emotional discomfort discussing lifestyle changes related to their health.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have had symptoms that suggest I might have had a stroke or a mini-stroke.
Select...
I currently use tobacco and it contributed to my stroke.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~90 days post-discharge
This trial's timeline: 3 weeks for screening, Varies for treatment, and 90 days post-discharge for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Patient rating of ability to improve their health
Recurrence of stroke / TIA symptoms
Smoking cessation at 90-day post-discharge follow up
Secondary outcome measures
Patient ability to take stroke prevention medications as prescribed

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Motivational InterviewExperimental Treatment1 Intervention
Patients included in the study who are being treated by a resident in the MI intervention group will have a motivational interview during their initial hospitalization.
Group II: ControlActive Control1 Intervention
Patients included in the study who are being treated by a resident in the Control group will not have a motivational interview during their hospitalization.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Motivational Interview
2013
Completed Phase 4
~4780

Find a Location

Who is running the clinical trial?

Accreditation Council for Graduate Medical EducationOTHER
4 Previous Clinical Trials
656 Total Patients Enrolled
University of FloridaLead Sponsor
1,341 Previous Clinical Trials
715,560 Total Patients Enrolled
19 Trials studying Stroke
2,277 Patients Enrolled for Stroke
Christine Wilson, MDStudy DirectorUniversity of Florida

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Which individuals are eligible to participate in this research study?

"Individuals aged 18 to 99 who have experienced a stroke are eligible for inclusion in this study. The research team aims to recruit approximately 86 participants."

Answered by AI

What is the current number of individuals who have been granted admission to participate in this clinical study?

"Indeed, the information sourced from clinicaltrials.gov indicates that this ongoing clinical trial is actively seeking individuals to participate. Initially posted on February 1st, 2024, and last edited on January 5th, 2024, the trial aims to enroll a total of 86 participants at one designated site."

Answered by AI

Does this clinical trial include individuals who are 85 years of age or older?

"To meet the eligibility requirements for this clinical trial, participants must be at least 18 years old and no older than 99 years of age."

Answered by AI

Are researchers actively seeking participants for this ongoing clinical trial?

"Indeed, the information provided on clinicaltrials.gov indicates that this trial is actively seeking individuals to participate. The trial was initially posted on February 1st, 2024 and most recently updated on January 5th, 2024. It aims to recruit a total of 86 participants from one specific location."

Answered by AI
~57 spots leftby Jul 2025